首页> 外文期刊>Nature clinical practice. Rheumatology >Is the risk of serious infections increased in patients with RA who receive treatment with antirheumatic drugs?
【24h】

Is the risk of serious infections increased in patients with RA who receive treatment with antirheumatic drugs?

机译:接受抗风湿药治疗的RA患者严重感染的风险是否增加?

获取原文
获取原文并翻译 | 示例
           

摘要

Disease-modifying antirheumatic drugs pMARDs), such as anti-tumor necrosis factor (TNF) agents and glucocorticoids, are most commonly used to treat patients with rheumatoid arthritis (RA). Increased risk of infection is a major concern in patients who use these drugs, especially considering that patients with RA are already immunocompromised.The objective of this study was to determine the risk of serious infection associated with the use of DMARDs and glucocorticoids in patients with RA.
机译:诸如抗肿瘤坏死因子(TNF)剂和糖皮质激素之类的疾病改良抗风湿药pMARDs最常用于治疗类风湿关节炎(RA)患者。感染风险增加是使用这些药物的患者的主要关注点,特别是考虑到RA患者已经免疫功能低下。本研究的目的是确定与DM患者使用DMARDs和糖皮质激素相关的严重感染风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号